Mycenax Biotech Inc.

EN

Please enter the company code as 4726 http://emops.twse.com.tw/server-java/t58query Go to Link

Dr. Karen Wen, the President of Mycenax, is invited to give a speech in "Biologics World Korea 2016".

Events
2016.06.27
Dr. Karen Wen, the President of Mycenax, is invited to give a speech in "Biologics World Korea 2016" on Jun. 29th and 30th.
Dr. Wen will share Mycenax's development of biosimilars, especially monoclonal antibody, and its proprietary one-step scaling up process. Moreover, LusiNEX, the in-house tocilizumab-biosimilar, will be showcased and sum up Mycenax's experience and expertise.